HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYS: TARO) ("Taro") reported today that it has received approval from the U.S. Food and Drug Administration ("FDA") for its New ...

Sun Pharmaceutical’s U.S.-based Taro Pharmaceutical Industries helped the Indian drugmaker boost its U.S. sales in its last fiscal year, but the skin care specialist has hit a small manufacturing ...

Perrigo Company plc PRGO recently announced that the FDA has approved its first-to-file AB rated generic version of Taro Pharmaceuticals USA Inc.'s TARO Topicort spray, 0.25% (desoximetasone topical ...

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (TARO) ("Taro") reported today that it has received approval from the U.S. Food and Drug Administration ("FDA") for its New Drug ...

Desoximetasone 0.25%. Avoid use on eyes, face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large ...

European satellite operator SES on Monday reported full-year results in line with market expectations and lowered its 2026 capital spending target, as it prepares to launch up to 13 satellites later ...

Lupin has received final approval for its Desoximetasone Ointment USP, 0.05 percent from the USFDA to market a generic version of Taro Pharms North's Topicort Ointment 0.05 percent. It has come to our ...

New Delhi, Jun 22: Drug firm Lupin today said it has launched generic Desoximetasone cream used for the treatment of inflammation and itching of skin, in the US market. The company has launched its ...

Perrigo Executive Vice President and President Rx Pharmaceuticals Sharon Kochan stated, "This launch exemplifies Perrigo's ongoing commitment to developing quality, high value alternatives in ...